搜尋
亞培
ABT添加自選
100.750USD
0.0000.00%
收盤 07-23 16:00（美東）報價延遲15分鐘
174.96B總市值
27.96本益比TTM
關於 亞培 公司
亞培是一家橫跨全球的醫療保健領導者，專注於多元健康產品的研發、製造與銷售，業務框架涵蓋四大單元：成熟藥品、診斷、營養以及醫療器械。成熟藥品單元負責多品牌仿製藥的國際行銷；診斷單元向血庫、醫院、商業實驗室與替代護理點提供檢測系統與試劑；營養單元經營成人及兒童營養品全球通路；醫療器械單元銷售節律管理、電生理、心衰、血管、結構心臟、神經調控及糖尿病護理裝置，持續推動創新改善患者生命品質。其全球供應鏈覆蓋六大洲，利用數據分析與可持續製造提升效率與品質保障。
亞培簡介
公司代碼ABT
公司名稱Abbott Laboratories
上市日期Apr 06, 2073
CEOFord (Robert B)
員工數量114000
證券類型Ordinary Share
年結日Apr 06
公司地址100 Abbott Park Road
城市ABBOTT PARK
上市交易所NASDAQ OMX NASDAQ Basic NYSE
國家United States of America
郵編60064-3500
電話12246676100
網址https://www.abbott.com
公司代碼ABT
上市日期Apr 06, 2073
CEOFord (Robert B)
亞培公司高管
名稱
名稱/職務
職務
持股
持股變動
Mr. Daniel J. Starks
Mr. Daniel J. Starks
Independent Director
Independent Director
6.75M
+0.18%
Mr. Daniel Gesua Sive Salvadori
Mr. Daniel Gesua Sive Salvadori
Executive Vice President, Group President - Established Pharmaceuticals and Nutritional Products
Executive Vice President, Group President - Established Pharmaceuticals and Nutritional Products
146.38K
-0.60%
Ms. Mary K. Moreland
Ms. Mary K. Moreland
Executive Vice President - Human Resources
Executive Vice President - Human Resources
104.29K
-0.59%
Ms. Lisa D. Earnhardt
Ms. Lisa D. Earnhardt
Executive Vice President, Group President - Medical Devices
Executive Vice President, Group President - Medical Devices
90.41K
+20.44%
Mr. Louis H. (Lou) Morrone
Mr. Louis H. (Lou) Morrone
Executive Vice President - Core Diagnostics
Executive Vice President - Core Diagnostics
76.57K
-0.35%
Mr. Philip P. Boudreau
Mr. Philip P. Boudreau
Chief Financial Officer, Executive Vice President - Finance
Chief Financial Officer, Executive Vice President - Finance
71.54K
+28.74%
Dr. Robert J. Alpern, M.D.
Dr. Robert J. Alpern, M.D.
Independent Director
Independent Director
40.80K
--
Ms. Sally E. Blount, Ph.D.
Ms. Sally E. Blount, Ph.D.
Independent Director
Independent Director
36.34K
+6.29%
Mr. John G. Stratton
Mr. John G. Stratton
Independent Director
Independent Director
23.32K
+8.58%
Ms. Michelle A. Kumbier
Ms. Michelle A. Kumbier
Independent Director
Independent Director
18.00K
+12.70%
查看更多
名稱
名稱/職務
職務
持股
持股變動
Mr. Daniel J. Starks
Mr. Daniel J. Starks
Independent Director
Independent Director
6.75M
+0.18%
Mr. Daniel Gesua Sive Salvadori
Mr. Daniel Gesua Sive Salvadori
Executive Vice President, Group President - Established Pharmaceuticals and Nutritional Products
Executive Vice President, Group President - Established Pharmaceuticals and Nutritional Products
146.38K
-0.60%
Ms. Mary K. Moreland
Ms. Mary K. Moreland
Executive Vice President - Human Resources
Executive Vice President - Human Resources
104.29K
-0.59%
Ms. Lisa D. Earnhardt
Ms. Lisa D. Earnhardt
Executive Vice President, Group President - Medical Devices
Executive Vice President, Group President - Medical Devices
90.41K
+20.44%
Mr. Louis H. (Lou) Morrone
Mr. Louis H. (Lou) Morrone
Executive Vice President - Core Diagnostics
Executive Vice President - Core Diagnostics
76.57K
-0.35%
Mr. Philip P. Boudreau
Mr. Philip P. Boudreau
Chief Financial Officer, Executive Vice President - Finance
Chief Financial Officer, Executive Vice President - Finance
71.54K
+28.74%
常見問題
亞培的前五大股東是誰？
亞培的前五大股東如下：Mr. Daniel J. Starks
有多少機構持有亞培(ABT)的股份？
截至2026Q1，共有4859家機構持有亞培的股份，合計持有的股份價值約為1.25B，占公司總股份的71.75% 。與2025Q4相比，機構持股有所增加，增幅為-187252308.00。
哪個業務部門對亞培的收入貢獻最大？
在2026Q1，Diabetes Care業務部門對亞培的收入貢獻最大，創收8.00B，占總收入的18.04% 。